Vietnam Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2030

Vietnam Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2030

Vietnam Active Pharmaceutical Ingredients (API) Market, By Therapeutic Class (Antibiotic, Cardiovascular, Lipid Lowering Drugs, Infectious Disease, Anesthetic, NSAIDS, Analgesic, Antiviral, Dermatology, Oncology, Endocrinology, Urology, Gastroenterology, Ophthalmology, Hormonal Agents, Muscle Relaxant, Parkinson, Psoriasis, Epileptic, Immunology, Hematology, Antineoplastic, Immunosuppressive Agents, and Others), Type ( Innovative Active Pharmaceutical Ingredient and Generic Active Pharmaceutical Ingredient), Type of Manufacturer (Captive Manufacturers and Merchant Manufacturer), Synthesis (Chemical Synthetic and Biotech), Type of Drug (Prescription Drugs and Over-the-Counter), Application (Clinical, Research), Potency (Traditional Potency Active Pharmaceutical Ingredient and High Potency Active Pharmaceutical Ingredient), Molecule (Small Molecule and Large Molecule), End User (Pharmaceutical Industries, Biotechnology Industries, Research and Academic Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (Vietnam) – Industry Trends & Forecast to 2030.

Market Definition

In Greek, the traditional word for Active Pharmaceutical Ingredients (API) is called pharmacon or pharmakon, which symbolizes a magical substance or drug. Active pharmaceutical ingredients as described in ICH Q7 is “any substance or combination of substances intended to be used in the manufacturing of a drug product, which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity. When more than one APIs is added to the drug, then it produces various therapeutic activities and can be used for the treatment of various diseases and control their symptoms. A small amount of active pharmaceutical ingredients is effective in providing a therapeutic effect in the body. The active pharmaceutical ingredients go under chemical changes during the manufacturing of the APIs and then it is present in the finished drug product in a modified form to provide a specific therapeutic effect.

Market Segmentation

Vietnam Active Pharmaceutical Ingredients (API) market is categorized into ten notable segments, which are based on the therapeutic class, type, type of manufacturer, synthesis, potency, type of drug, molecule, application, end user and distribution channel
• On the basis of therapeutic class, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into antibiotic, cardiovascular, lipid-lowering drugs, infectious disease, anesthetic, NSAIDs, analgesic, antiviral, dermatology, oncology, endocrinology, urology, gastroenterology, ophthalmology, hormonal agents, muscle relaxant, parkinson, psoriasis, epileptic, immunology, hematology, antineoplastic, immunosuppressive agents, and others
• On the basis of type, the Vietnam active pharmaceutical ingredients (API) market is segmented into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients
• On the basis of type of manufacturer, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into captive manufacturers and merchant manufacturers
• On the basis of synthesis, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into chemical synthetic, and biotech. Chemical synthesis is further sub-segmented into saxagliptin, enoxaparin sodium, rufinamide, tamoxifen, artemisinin, losartan potassium, naproxen, ibuprofen acetaminophen, sodium chloride and others. The biotech segment is further sub-segmented into monoclonal antibodies, cytokines, hormones & growth factors, blood factors, recombinant vaccines, and therapeutic enzymes
• On the basis of potency, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into traditional potency active pharmaceutical ingredients and high potency active pharmaceutical ingredients
• On the basis of type of drug, the Vietnam active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs
• On the basis of molecule, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into small molecule, and large molecule
• On the basis of application, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into clinical and research
• On the basis of end user, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into pharmaceutical industries, biotechnology industries, research and academic institutes and other pharmaceutical industries is further segmented into large, medium, and small. Biotechnology is further segmented into large, medium, and small
• On the basis of distribution channel, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into direct tenders, retail sales, and others

Market Players:

Some of the key market players for Vietnam Active Pharmaceutical Ingredients (API) market are listed below:
• Pfizer Inc.
• MEKOPHAR
• AstraZeneca
• Divi's Laboratories Limited
• Sanofi
• Dr. Reddy’s Laboratories Ltd.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• BASF SE
• Novo Nordisk A/S
• GSK plc
• Jubilant Pharma Limited
• Lupin
• C.H. Boehringer Sohn AG & Co. KG
• Unichem Laboratories

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.